NBT Bank N A NY Lowers Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

NBT Bank N A NY lessened its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.8% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 29,474 shares of the financial services provider’s stock after selling 849 shares during the period. NBT Bank N A NY owned 0.06% of iShares Biotechnology ETF worth $4,046,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Baltimore Washington Financial Advisors Inc. increased its holdings in shares of iShares Biotechnology ETF by 3.0% in the second quarter. Baltimore Washington Financial Advisors Inc. now owns 7,411 shares of the financial services provider’s stock valued at $1,017,000 after purchasing an additional 213 shares during the period. Concurrent Investment Advisors LLC increased its stake in iShares Biotechnology ETF by 21.3% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 3,589 shares of the financial services provider’s stock valued at $493,000 after buying an additional 630 shares during the period. Rothschild Investment LLC purchased a new position in iShares Biotechnology ETF during the 2nd quarter worth $412,000. Blue Fin Capital Inc. lifted its stake in shares of iShares Biotechnology ETF by 0.7% in the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock worth $1,443,000 after acquiring an additional 74 shares during the period. Finally, International Assets Investment Management LLC boosted its holdings in shares of iShares Biotechnology ETF by 7.3% in the second quarter. International Assets Investment Management LLC now owns 2,929 shares of the financial services provider’s stock valued at $402,000 after acquiring an additional 200 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 0.1 %

Shares of iShares Biotechnology ETF stock opened at $148.17 on Friday. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $150.17. The company’s 50-day simple moving average is $143.44 and its 200-day simple moving average is $137.67.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.